Yacht maker designs a 'hospital boat' concept
The concept of a floating hospital, or a ‘hospital boat’ to be more precise, has been coined by an Italian yacht designer, newspaper the Daily Mail is reporting.
Mario Alfani, an Italian yacht specialist, was inspired to create the concept after one of his close friends spent time working as part of a medical mission on the African continent.
It features high-tech theatre facilities, testing labs and recovery wards and also boasts a heli-pad and an ambulance storage space.
Earlier this month the hospital boat concept was awarded a prize at the 2012 Millennium Yacht Design Awards.
To read the latest edition of Healthcare Global, click here
- Patients to be prescribed smartphone health apps by GPs
- Combining drugs boosts pancreatic cancer treatment
- Model agencies in UK ban models from using sunbeds
Alfani said he has modelled the design of the hospital boat on Italy’s Bergamo Hospital.
However, its catamaran-style concept means that it would be able to dock close to the shore or on beaches.
Accoridng to the Daily Mail, his theory behind the hospital boat is that it could be used to rescue victims of natural disasters such as tsunamis, or incidents like the recent sinking of the Costa Concordia cruise liner.
He also hopes that it would prove to be useful for those living in rural coastal areas who have limited access to hospitals, or residents whose local hospital or health facility has outdated infrastructure.
Based on Alfani’s designs the hospital boat has the capacity to treat 50 patients a day, who would be tended to by nine nurses and doctors and three crew members.
He has suggested that aluminium alloy would be used to manufacture the boat.
Commenting on his innovative concept, Alfani told local news source L'Eco Di Bergamo: “The earth is surrounded by water and it is unthinkable that there is no tool that allows immediate first aid at sea.”
The Healthcare Global magazine is now available on the iPad. Click here to download it.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”